Unlocking Duel Benifits SGLT2i in CKD and Obesity

202 views
  Streamed on 28 Mar, 2025, 07:00 PM

ABOUT THIS SESSION

This webinar explores the emerging role of SGLT2 inhibitors in the management of chronic kidney disease (CKD) and obesity. Experts will discuss the latest clinical evidence highlighting the dual benefits of these agents, including renal protection, cardiovascular outcomes, and metabolic improvements. Join us to gain insights into optimizing patient care with this evolving therapeutic approach

FACULTY
Dr. Vikram Kalra
Dr. Vikram Kalra
Additional Director, Department of Nephrology and Renal Transplant Medicine at Aakash Healthcare, Dwarka.

Latest Archive Videos

Management Of Diabetic Kidney Disease:The Era Of The Four Pillars

Management Of Diabetic Kidney Disease:The Era Of The Four Pillars

Managing Anemia in CKD: Recent Advances and Practical Approaches

Managing Anemia in CKD: Recent Advances and Practical Approaches

Blood Pressure Control in CKD: Guidelines and Practical Aproaches For Patients With or without Diabetes

Blood Pressure Control in CKD: Guidelines and Practical Aproaches For Patients With or without Diabetes

MORE FROM PRACTICE MANAGEMENT

Management Of Diabetic Kidney Disease:The Era Of The Four Pillars

Management Of Diabetic Kidney Disease:The Era Of The Four Pillars

Cardiovascular Health in CKD

Cardiovascular Health in CKD

CKD:Diagnosis monitoring and Management

CKD:Diagnosis monitoring and Management

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ
About Us
Medtalks TV
Contact Us
Webinars
Privacy Policy
CMEs
Terms And Conditions
Conferences

Connect With Us